The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2022 | Key challenges in the management of extramedullary and CNS disease in patients with multiple myeloma
Tiffany Richards, MS, ANP, AOCNP, MD Anderson Cancer Center, San Antonio, Texas, outlines the challenges in the management of extramedullary and central nervous system (CNS) disease in patients with multiple myeloma, including lack of data on effective therapies, differentiating between extramedullary disease subtypes, and communicating the impact of extramedullary and CNS diseases with patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
